Neurological Complications in Pregnant Women with Polycystic Ovary Syndrome (PCOS) and Their Impact on Maternal Health
DOI:
https://doi.org/10.52783/jns.v14.3983Keywords:
Polycystic Ovary Syndrome (PCOS), Neurological complications, Pregnancy, Headaches, Anxiety, Depression, Sleep disturbances, Maternal outcomes, Gestational diabetes, Preterm labor, Cesarean deliveryAbstract
Objective: This study aimed to investigate the neurological complications in pregnant women with Polycystic Ovary Syndrome (PCOS) and their impact on maternal health outcomes.
Methods: A prospective observational study was conducted over 1 year, enrolling 41 pregnant women diagnosed with PCOS according to the Rotterdam criteria. Neurological symptoms such as headaches, mood disorders, sleep disturbances, and seizures were assessed using standardized tools. Maternal outcomes including gestational hypertension, gestational diabetes, preeclampsia, preterm labor, and mode of delivery were also recorded. Data analysis was performed using SPSS software.
Results: Neurological complications were common, with headaches (43.9%), anxiety (34.1%), depression (24.4%), and sleep disturbances (39.0%) observed. Anxiety and depression were significantly associated with an increased rate of cesarean delivery (p = 0.048), while sleep disturbances were linked to preterm labor (p = 0.032). Maternal complications included gestational diabetes (26.8%), gestational hypertension (17.1%), and preeclampsia (9.8%).
Conclusions: Neurological complications in pregnant women with PCOS are associated with adverse maternal outcomes. Early recognition and management of these complications could help improve both maternal and neonatal health. Integrated care involving neurological and psychological assessments is essential for improving pregnancy outcomes in women with PCOS.
Downloads
Metrics
References
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602–1618.
Hussain M, El-Nashar SA, Famuyide AO, et al. Neurological disorders in women with polycystic ovary syndrome: A systematic review. J Clin Endocrinol Metab. 2020;105(3):dgz204.
Kaur H, Jindal A, Aggarwal S. Anxiety and depression in polycystic ovary syndrome: A cross-sectional study. Indian J Psychol Med. 2021;43(3):208–212.
Palomba S, Santagni S, Falbo A, La Sala GB. Complications and challenges associated with PCOS and pregnancy. J Clin Endocrinol Metab. 2015;100(3):107–114.
Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(6):673–683.
Dokras A, Stener-Victorin E, Yildiz BO, et al. Androgen excess, metabolic dysfunction, and psychological implications in PCOS: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab. 2018;103(2):e756–e774.
Torelli P, Abrignani G, Lambru G, et al. Migraine and hormonal changes in women. Neurol Sci. 2021;42(Suppl 1):85–90.
Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: Effects on intracellular magnesium. Headache. 1991;31(5):298–301.
Rasgon NL, Rao RC, Hwang S, Altshuler LL, Elman S. Depression in women with PCOS: Clinical implications. Curr Psychiatry Rep. 2020;22(11):58.
March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of PCOS in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544–551.
Jacewicz R, Wozniak A, Brożyna-Tkaczyk K. Sleep disorders in patients with PCOS: A review. Int J Environ Res Public Health. 2023;20(4):3601.
Vgontzas AN, Legro RS, Bixler EO, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: Role of insulin resistance. J Clin Endocrinol Metab. 2001;86(2):517–520.
Rizzo MR, Barbieri M, Marfella R, et al. Reduction of oxidative stress and inflammation by glycemic control in patients with newly diagnosed type 2 diabetes. Diabetes Care. 2002;25(11):2130–2131.
Tan BL, Norhaizan ME, Liew WP, Sulaiman Rahman H. Antioxidant and oxidative stress: A mutual interplay in age-related diseases. Front Pharmacol. 2018;9:1162.
Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with PCOS: Population-based cohort study. BMJ. 2011;343:d6309.
Qublan HS, Ammarin V, Bataineh O, et al. Luteinizing hormone and testosterone levels in women with PCOS: Relationship with insulin resistance and adverse pregnancy outcomes. Gynecol Endocrinol. 2006;22(2):82–87.
Martin VT, Behbehani M. Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis. Headache. 2006;46(Suppl 2):S3–S23.
Yen SS, Jaffe RB. Reproductive Endocrinology. 6th ed. Elsevier Saunders; 2019.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
